Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 May;28(3):360-2.
doi: 10.1111/pcmr.12356. Epub 2015 Feb 17.

Major association of vitiligo with HLA-A*02:01 in Japanese

Affiliations

Major association of vitiligo with HLA-A*02:01 in Japanese

Ying Jin et al. Pigment Cell Melanoma Res. 2015 May.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Major histocompatibility complex association results for vitiligo in Japanese. Results of association of 1649 MHC region single-nucleotide polymorphisms (SNPs; black dots). SNPs are ordered by physical genomic position (GRCh37/hg19) versus −Log10(P value).

Similar articles

Cited by

References

    1. Birlea SA, Spritz RA, Norris DA. Vitiligo. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick’s Dermatology in General Medicine. 8th ed. McGraw-Hill; New York: 2012.
    1. de Bakker PI, McVean G, Sabeti PC, et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat. Genet. 2006;38:1166–1172. - PMC - PubMed
    1. Devlin B, Roeder K, Wasserman L. Genomic control, a new approach to genetic-based association studies. Theor. Popul. Biol. 2001;60:155–166. - PubMed
    1. Jin Y, Birlea SA, Fain PR, et al. Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. N. Engl. J. Med. 2010;362:1686–1697. - PMC - PubMed
    1. Jin Y, Ferrara T, Gowan K, et al. DNA re-sequencing identifies common variants of TYR (tyrosinase) and HLA-A that together modulate risk of generalized vitiligo via antigenic presentation. J. Invest. Dermatol. 2012;132:1730–1733. - PMC - PubMed

Publication types